Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | -- | 0.00 | 0.00 | -- |
| Operating Revenue | 0.00 | -- | 0.00 | 0.00 | -- |
| Selling General And Administration | 570,831 | -- | 417,441 | 403,833 | -- |
| General And Administrative Expense | 470,901 | -- | 358,220 | 335,722 | -- |
| Research And Development | 112,282 | -- | 45,050 | 22,771 | -- |
| Depreciation And Amortization In Income Statement | 18,721 | -- | 19,815 | 19,814 | -- |
| Other Operating Expenses | -- | -- | 0.00 | -- | -- |
| Operating Expense | 701,834 | -- | 482,306 | 446,418 | -- |
| Operating Income | -701,834 | -- | -482,306 | -446,418 | -- |
| EBIT | -706,549 | -- | -811,736 | -444,821 | -- |
| Interest Expense | 2,137 | -- | 577.00 | 803.00 | -- |
| Interest Expense Non Operating | 2,137 | -- | 577.00 | 803.00 | -- |
| Interest Income | 1,840 | -- | 3,178 | 996.00 | -- |
| Interest Income Non Operating | 1,840 | -- | 3,178 | 996.00 | -- |
| Net Interest Income | -297.00 | -- | 2,601 | 193.00 | -- |
| Other Income Expense | -6,555 | -- | -332,608 | 601.00 | -- |
| Special Income Charges | -5,593 | -- | -316,520 | -790.00 | -- |
| Gain On Sale Of Security | -962.00 | -- | -16,088 | 1,391 | -- |
| Pretax Income | -708,686 | -- | -812,313 | -445,624 | -- |
| Tax Effect Of Unusual Items | 0.00 | -- | 0.00 | 0.00 | -- |
| Net Income From Continuing And Discontinued Operation | -708,686 | -- | -812,313 | -445,624 | -- |
| Net Income From Continuing Operation Net Minority Interest | -708,686 | -- | -812,313 | -445,624 | -- |
| Net Income Including Noncontrolling Interests | -708,686 | -- | -812,313 | -445,624 | -- |
| Net Income Common Stockholders | -708,686 | -- | -812,313 | -445,624 | -- |
| Net Income | -708,686 | -- | -812,313 | -445,624 | -- |
| EBITDA | -687,828 | -- | -791,921 | -425,007 | -- |
| Normalized EBITDA | -681,273 | -- | -459,313 | -425,608 | -- |
| Reconciled Depreciation | 18,721 | -- | 19,815 | 19,814 | -- |
| Basic EPS | -0.01 | -0.01 | -- | -0.01 | -0.01 |
| Diluted EPS | -0.01 | -0.01 | -- | -0.01 | -0.01 |
| Basic Average Shares | 61.7M | 61.7M | -- | 61.7M | 61.7M |
| Diluted Average Shares | 61.7M | 61.7M | -- | 61.7M | 61.7M |
| Total Unusual Items | -6,555 | -- | -332,608 | 601.00 | -- |
| Total Unusual Items Excluding Goodwill | -6,555 | -- | -332,608 | 601.00 | -- |
| Tax Rate For Calcs | 0.00 | -- | 0.00 | 0.00 | -- |
| Normalized Income | -702,131 | -- | -479,705 | -446,225 | -- |
| Depreciation Amortization Depletion Income Statement | 18,721 | -- | 19,815 | 19,814 | -- |
| Depreciation Income Statement | 18,721 | -- | 19,815 | 19,814 | -- |
| Diluted NI Availto Com Stockholders | -708,686 | -- | -812,313 | -445,624 | -- |
| Gain On Sale Of Ppe | -153.00 | -- | -- | 0.00 | -- |
| Insurance And Claims | 2,018 | -- | 859.00 | 859.00 | -- |
| Net Income Continuous Operations | -708,686 | -- | -812,313 | -445,624 | -- |
| Net Non Operating Interest Income Expense | -297.00 | -- | 2,601 | 193.00 | -- |
| Other Gand A | 294,395 | -- | 189,688 | 163,245 | -- |
| Other Special Charges | 5,440 | -- | 1,958 | 790.00 | -- |
| Salaries And Wages | 174,488 | -- | 167,673 | 171,618 | -- |
| Selling And Marketing Expense | 99,930 | -- | 59,221 | 68,111 | -- |
| Total Expenses | 701,834 | -- | 482,306 | 446,418 | -- |
| Total Operating Income As Reported | -707,274 | -- | -484,264 | -447,208 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 59,953 | -- | 360,177 | -- | -- |
| Cash Cash Equivalents And Short Term Investments | 59,953 | -- | 360,177 | -- | -- |
| Receivables | 17,369 | -- | 66,547 | -- | -- |
| Prepaid Assets | 191,683 | -- | 123,904 | -- | -- |
| Current Assets | 3.1M | -- | 550,628 | -- | -- |
| Gross PPE | 308,587 | -- | 269,824 | -- | -- |
| Accumulated Depreciation | -177,793 | -- | -120,980 | -- | -- |
| Net PPE | 130,794 | -- | 148,844 | -- | -- |
| Total Non Current Assets | 130,794 | -- | 148,844 | -- | -- |
| Total Assets | 3.2M | -- | 699,472 | -- | -- |
| Current Debt And Capital Lease Obligation | 22,674 | -- | 13,169 | -- | -- |
| Accounts Payable | 427,231 | -- | 147,573 | -- | -- |
| Payables | 427,231 | -- | 147,573 | -- | -- |
| Payables And Accrued Expenses | 557,602 | -- | 246,319 | -- | -- |
| Current Accrued Expenses | 130,371 | -- | 98,746 | -- | -- |
| Current Liabilities | 580,276 | -- | 259,488 | -- | -- |
| Long Term Debt And Capital Lease Obligation | -- | -- | 0.00 | -- | -- |
| Long Term Capital Lease Obligation | -- | -- | 0.00 | -- | -- |
| Total Non Current Liabilities Net Minority Interest | 0.00 | -- | 0.00 | -- | -- |
| Total Liabilities Net Minority Interest | 580,276 | -- | 259,488 | -- | -- |
| Common Stock | 7.2M | -- | 3.5M | -- | -- |
| Capital Stock | 7.2M | -- | 3.5M | -- | -- |
| Retained Earnings | -5.4M | -- | -3.5M | -- | -- |
| Gains Losses Not Affecting Retained Earnings | 827,021 | -- | 401,498 | -- | -- |
| Other Equity Adjustments | 827,021 | -- | 401,498 | -- | -- |
| Common Stock Equity | 2.7M | -- | 439,984 | -- | -- |
| Stockholders Equity | 2.7M | -- | 439,984 | -- | -- |
| Total Equity Gross Minority Interest | 2.7M | -- | 439,984 | -- | -- |
| Total Capitalization | 2.7M | -- | 439,984 | -- | -- |
| Net Tangible Assets | 2.7M | -- | 439,984 | -- | -- |
| Tangible Book Value | 2.7M | -- | 439,984 | -- | -- |
| Working Capital | 2.5M | -- | 291,140 | -- | -- |
| Invested Capital | 2.7M | -- | 439,984 | -- | -- |
| Total Debt | 22,674 | -- | 13,169 | -- | -- |
| Share Issued | 61.7M | 61.7M | 61.7M | -- | -- |
| Ordinary Shares Number | 61.7M | 61.7M | 61.7M | -- | -- |
| Capital Lease Obligations | 22,674 | -- | 13,169 | -- | -- |
| Current Capital Lease Obligation | 22,674 | -- | 13,169 | -- | -- |
| Other Properties | 308,587 | -- | 269,824 | -- | -- |
| Other Receivables | -- | -- | 50,000 | -- | -- |
| Restricted Cash | 2.8M | -- | -- | -- | -- |
| Taxes Receivable | 17,369 | -- | 16,547 | -- | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 | Q2 2024Jun 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -542,240 | -- | -428,048 | -417,863 | -- |
| Cash Flow From Continuing Operating Activities | -542,240 | -- | -428,048 | -417,863 | -- |
| Depreciation And Amortization | 18,721 | -- | 19,815 | 19,814 | -- |
| Depreciation Amortization Depletion | 18,721 | -- | 19,815 | 19,814 | -- |
| Change In Working Capital | 148,722 | -- | 41,361 | 7,862 | -- |
| Changes In Account Receivables | 21,492 | -- | -23,718 | 12,112 | -- |
| Change In Receivables | 21,492 | -- | -23,718 | 12,112 | -- |
| Change In Payables And Accrued Expense | 127,230 | -- | 65,079 | -4,250 | -- |
| Other Non Cash Items | -1,038 | -- | -2,636 | -193.00 | -- |
| Capital Expenditure | -797.00 | -- | -- | -70,720 | -- |
| Purchase Of PPE | -797.00 | -- | 70,720 | -70,720 | -- |
| Net PPE Purchase And Sale | -647.00 | -- | 70,720 | -70,720 | -- |
| Purchase Of Investment | -- | -- | -228,920 | -- | -- |
| Net Investment Purchase And Sale | -- | -- | -228,920 | -- | -- |
| Investing Cash Flow | 1,193 | -- | -225,742 | -69,724 | -- |
| Cash Flow From Continuing Investing Activities | 1,193 | -- | -225,742 | -69,724 | -- |
| Repayment Of Debt | -10,088 | -- | -10,088 | -10,087 | -- |
| Net Issuance Payments Of Debt | -10,088 | -- | -10,088 | -10,087 | -- |
| Issuance Of Capital Stock | 70,735 | -- | 1.0M | 242,500 | -- |
| Net Common Stock Issuance | 70,735 | -- | 1.0M | 242,500 | -- |
| Financing Cash Flow | 48,568 | -- | 936,612 | 210,363 | -- |
| Cash Flow From Continuing Financing Activities | 48,568 | -- | 936,612 | 210,363 | -- |
| Effect Of Exchange Rate Changes | -355.00 | -- | -1,136 | 272.00 | -- |
| Changes In Cash | -492,479 | -- | 282,822 | -277,224 | -- |
| Beginning Cash Position | 552,787 | -- | 78,491 | 355,443 | -- |
| End Cash Position | 59,953 | -- | 360,177 | 78,491 | -- |
| Free Cash Flow | -543,037 | -- | -357,328 | -488,583 | -- |
| Common Stock Issuance | 70,735 | -- | 1.0M | 242,500 | -- |
| Depreciation | 18,721 | -- | 19,815 | 19,814 | -- |
| Gain Loss On Sale Of PPE | 153.00 | -- | -- | 0.00 | -- |
| Interest Received Cfi | 1,840 | -- | 3,178 | 996.00 | -- |
| Long Term Debt Payments | -10,088 | -- | -10,088 | -10,087 | -- |
| Net Foreign Currency Exchange Gain Loss | -112.00 | -- | 11,163 | 278.00 | -- |
| Net Income From Continuing Operations | -708,686 | -- | -812,313 | -445,624 | -- |
| Net Long Term Debt Issuance | -10,088 | -- | -10,088 | -10,087 | -- |
| Net Other Financing Charges | -12,079 | -- | -79,300 | -22,050 | -- |
| Operating Gains Losses | 41.00 | -- | 11,163 | 278.00 | -- |
| Sale Of PPE | 150.00 | -- | -- | 0.00 | -- |